Wilson Sonsini Goodrich & Rosati represented General Atlantic on the transaction. CinCor Pharma, Inc. announced the completion of a $143 million Series B financing. The financing...
CinCor Pharma’s $143 Million Series B Financing
Clearway Energy’s Solar and Energy Storage Project in Southern California
Wilson Sonsini Goodrich & Rosati advised Clearway Energy on the deal. Clearway Energy Group LLC announced the start of full construction at its Daggett 3 Solar...
BIOMILQ, Inc.’s $21 Million Series A Financing
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the deal. North Carolina-based mammary biotechnology company BIOMILQ, Inc., announced the successful close of $21 million in...
Crinetics’ Launch of Radionetics Oncology
Wilson Sonsini Goodrich & Rosati advised Crinetics on the deal. Crinetics Pharmaceuticals, a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel...
Best Buy’s Acquisition of Current Health
Wilson Sonsini Goodrich & Rosati and Taylor Wessing advised Current Health on the deal. Best Buy announced it had signed an agreement to acquire Current Health,...
Plume’s $300 Million Series F Financing Round
Wilson Sonsini Goodrich & Rosati advised Plume on the deal. Plume, the creator of the world’s first SaaS experience platform for communications service providers (CSPs) and...
NanoCellect’s $35 Million Series C & D Financing
Wilson Sonsini Goodrich & Rosati advised NanoCellect on the deal. Microfluidic cell sorting company NanoCellect Biomedical announced the closing of $35 million in Series C and...
Transcarent’s Partnership with Walmart
Wilson Sonsini Goodrich & Rosati advised Transcarent on the deal. Walmart and Transcarent announced that they will be working together as go-to-market partners for self-insured employers...
FREYR’s Joint Venture with Koch Strategic Platforms
Wilson Sonsini Goodrich & Rosati advised FREYR on the deal. FREYR Battery, a developer of clean, next-generation battery cell production capacity, announced the formation of a...
Avalara’s Acquisition of Track 1099
Wilson Sonsini Goodrich & Rosati advised Track 1099 on the deal. Avalara, a leading provider of tax compliance automation software for businesses of all sizes, has acquired...
ALX Oncology’s Acquisition of ScalmiBio
Wilson Sonsini Goodrich & Rosati advised ALX Oncology on the deal. ALX Oncology Holdings Inc. (ALX Oncology), a clinical-stage immuno-oncology company, and ScalmiBio, Inc., announced that...
Thorne HealthTech’s $70 Million Initial Public Offering
Wilson Sonsini Goodrich & Rosati represented Thorne HealthTech, while Latham & Watkins represented the underwriters in the offering. Thorne HealthTech, a leader in developing innovative solutions...